How much revenue did Novartis India generate this year?
Novartis India has achieved a revenue of 3.35 B INR this year.
In 2024, Novartis India's sales reached 3.35 B INR, a -11.53% difference from the 3.79 B INR sales recorded in the previous year.
YEAR | REVENUE (undefined INR) | GROSS MARGIN (%) |
---|---|---|
2024 | 3.35 | 40,36 |
2023 | 3.79 | 45,97 |
2022 | 4 | 54,62 |
2021 | 3.81 | 60,76 |
2020 | 4.38 | 57,70 |
2019 | 4.91 | 58,81 |
2018 | 5.64 | 55,71 |
2017 | 6.56 | 52,54 |
2016 | 6.9 | 57,73 |
2015 | 8.73 | 58,39 |
2014 | 8.62 | 53,19 |
2013 | 9.03 | 58,86 |
2012 | 8.44 | 63,11 |
2011 | 7.51 | 63,62 |
2010 | 6.24 | 59,83 |
2009 | 5.99 | 58,67 |
2008 | 5.53 | 56,51 |
2007 | 5.42 | 55,00 |
2006 | 5.26 | 50,85 |
2005 | 4.71 | 52,06 |
The sales figures of Novartis India originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Analyzing Novartis India’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Investors often scrutinize Novartis India's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Increases in Novartis India’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Novartis India has achieved a revenue of 3.35 B INR this year.
The revenue of Novartis India has increased by -11.53% decreased compared to the previous year.
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
The revenue of Novartis India is influenced by various factors, including the demand for its products and services, market conditions, and prices.
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
The revenue of Novartis India is an important indicator of financial performance and attractiveness for investors.
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
Over the past 12 months, Novartis India paid a dividend of 10 INR . This corresponds to a dividend yield of about 1 %. For the coming 12 months, Novartis India is expected to pay a dividend of 10 INR.
The current dividend yield of Novartis India is 1 %.
Novartis India pays a quarterly dividend. This is distributed in the months of September, August, August, August.
Novartis India paid dividends every year for the past 0 years.
For the upcoming 12 months, dividends amounting to 10 INR are expected. This corresponds to a dividend yield of 1 %.
Novartis India is assigned to the 'Health' sector.
To receive the latest dividend of Novartis India from 8/5/2024 amounting to 25 INR, you needed to have the stock in your portfolio before the ex-date on 7/23/2024.
The last dividend was paid out on 8/5/2024.
In the year 2023, Novartis India distributed 10 INR as dividends.
The dividends of Novartis India are distributed in INR.
Our stock analysis for Novartis India Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Novartis India Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.